Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 16, 2019 10:44am
72 Views
Post# 29830111

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:200,000 Warrants Converted

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:200,000 Warrants Converted
skier59 wrote: Hey JohnnyBJ are you a shareholder now? BTW many of us do appreciate and understand most of Claridge's posts. I'm actually happy the SP hasn't taken off yet. A few years ago I was really happy to have 50,000 shares, now with over 200,000 I'm super excited for the next couple of years. I suppose I have to thank you for your efforts over the years in working your talents to keep the SP from breaking out. You are very good with your words, very creative, and I have to give you top marks for always being polite.


Skier59, I'll excuse your snarky remarks because I don't really think you in your heart of hearts believe that I had anything to do with the performance of the sp. Like most on this board I am equally mystified why the sp isn't higher based on the results of the phase 1b clinical trial. What the reasons are is open to discussion in a grown up manner and from the perspective of an investor without hinderance from such egotistical characters as Claridge who will systematically turn any informative discussion into a bar room brawl. I firmly believe this board is much better off without his bullying tactics as it increases participation among the less prolific posters. I said reading this board was like a breath of fresh air when Claridge was not allowed to post and I meant it.

Bullboard Posts